USD 11.82 billion
Hemophilia Treatment Market Size, Share, Growth Analysis, By Type(Hemophilia A and Hemophilia B), By Distributor Channel(Hospital Pharmacies and Specialty Pharmacies), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35D2171 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
59
|Figures:
75
Hemophilia Treatment Market Insights
Hemophilia Treatment Market size was valued at USD 12.60 billion in 2022 and is poised to grow from USD 13.43 billion in 2023 to USD 22.40 billion by 2031, at a CAGR of 6.6% during the forecast period (2024-2031)
Global Hemophilia Treatment Market has witnessed significant growth in recent years due to advancements in medical technology, increased awareness about the disorder, and improved access to healthcare services in various regions worldwide. The market encompasses a wide range of products and services designed to address the unique needs of individuals with hemophilia, including clotting factor concentrates, gene therapy, and supportive care. Clotting factor concentrates, such as recombinant factor VIII and factor IX, are commonly used for the treatment of hemophilia A and B, respectively. These concentrates help replace the missing clotting factors in patients, thereby reducing the risk of bleeding episodes and related complications. Gene therapy, on the other hand, holds promise as a potential curative approach by introducing functional genes to correct the underlying genetic defects responsible for hemophilia. The global Hemophilia Treatment Market is driven by several factors, including the increasing prevalence of hemophilia, rising healthcare expenditure, and a growing emphasis on personalized medicine. Moreover, advancements in genetic engineering and biotechnology have paved the way for innovative treatment options, providing new avenues for managing and potentially curing hemophilia. In conclusion, the global market is a dynamic and rapidly evolving sector that aims to provide effective therapeutic options for individuals with hemophilia. With ongoing research and innovation, there is a continuous focus on improving treatment outcomes, reducing complications, and ultimately finding a cure for this challenging genetic disorder.
US Hemophilia Treatment Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Hemophilia A
Fastest Growth
Hemophilia A
Growth Rate
6.6% CAGR
Global Hemophilia Treatment Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Hemophilia Treatment Market Segmental Analysis
The global Hemophilia Treatment market is segmented on the basis of type, distributor channel, and region. By type, the market is segmented into Hemophilia A and Hemophilia B. By distributor channel, the market is segmented into Hospital Pharmacies and Specialty Pharmacies. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Hemophilia Treatment Market Analysis By Type
The global Hemophilia Treatments market can be segmented based on product types, including Hemophilia A and Hemophilia B. The dominant segment in the global Hemophilia Treatments market is Hemophilia A. It holds the highest share of 74.16%. It is the most common type of hemophilia, accounting for a majority of hemophilia cases worldwide. As a result, the Hemophilia A segment holds a significant market share due to the larger patient population requiring treatment for this specific type of hemophilia.
The fastest-growing segment in the global Hemophilia Treatments market is Hemophilia B. Advances in medical research and technology have led to the development of improved treatment options and therapies for Hemophilia B. Additionally, increased awareness, better diagnosis, and accessibility to healthcare services have contributed to the growing demand for Hemophilia B treatments.
Hemophilia Treatment Market Analysis By Distributor Channel
The global Hemophilia Treatments market can also be segmented based on the distributor channel used, including Hospital Pharmacies and Specialty Pharmacies. The dominant segment in the global Hemophilia Treatments market is specialty pharmacies. It holds market share of 61.4%. Haemophilia is an uncommon and difficult condition, and only a small number of qualified individuals can provide treatment. The majority of haemophiliacs in the United States are treated at "haemophilia treatment centres," or HTCs as they are more often called. The majority of HTCs have interdisciplinary teams with extensive expertise in managing haemophilia, and they mostly source their medication needs from specialised pharmacies.
The fastest-growing segment in the global Hemophilia Treatments market is hospital pharmacies. This segment is expected to grow at fastest CAGR of 7.1%. The approval of gene therapy, which would primarily be given in hospitals because it needs constant side effect monitoring, is anticipated to fuel segment expansion. Additionally, some HTCs have connections to hospitals.
Global Hemophilia Treatment Market By Type
To get detailed analysis on other segments, Request For Free Sample Report
Hemophilia Treatment Market Regional Insights
North America dominated the global Hemophilia Treatment market. The region has well-established healthcare infrastructure, advanced medical technologies, and favorable reimbursement policies, contributing to its dominant position. The presence of major pharmaceutical companies and research institutions in North America further strengthens its market dominance. Additionally, a high prevalence of hemophilia cases in North America drives the demand for hemophilia treatment, resulting in a larger market share002E
The fastest-growing region in the global Hemophilia Treatment market is Asia Pacific. The region has witnessed significant advancements in healthcare infrastructure, increased accessibility to healthcare services, and rising awareness about hemophilia. Additionally, the growing population and improving economic conditions in countries like China and India contribute to the expansion of the market in the Asia Pacific region. Furthermore, government initiatives to improve healthcare facilities and increase healthcare expenditure are boosting the growth of the Hemophilia Treatment Market in this region.
Global Hemophilia Treatment Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Hemophilia Treatment Market Dynamics
Hemophilia Treatment Market Drivers
Increasing technological advancement
- A positive market outlook is provided by the fact that top industry players are concentrating on delivering technologically cutting-edge diagnostic tools and medicines to improve the efficacy and accuracy of haemophilia treatment. The market is also expected to be driven by significant expenditures in the global expansion of specialised haemophilia treatment centres (HTCs).
Hemophilia Treatment Market Restraints
Stringent Regulatory Approval Processes
- The stringent regulatory approval processes imposed by regulatory authorities can pose challenges for market growth. Manufacturers must comply with safety and efficacy assessments, which can be time-consuming and resource-intensive, delaying the market entry of new products.
Request Free Customization of this report to help us to meet your business objectives.
Hemophilia Treatment Market Competitive Landscape
The competitive landscape in the Global Hemophilia Treatment Market is characterized by a mix of well-established pharmaceutical companies and emerging biotechnology firms. The market is highly competitive, with players striving to gain a significant share by offering innovative therapies and services for individuals with hemophilia. Additionally, regulatory approvals and intellectual property rights play a crucial role in shaping the competitive dynamics. Companies with strong intellectual property portfolios and a track record of obtaining regulatory approvals gain a competitive edge, as it ensures exclusivity and market exclusivity for their products. Overall, the competitive landscape in the Hemophilia Treatment Market is dynamic and evolving, with established pharmaceutical companies and innovative biotechnology firms competing to provide effective therapies, improve patient outcomes, and address the unmet needs of individuals with hemophilia.
Hemophilia Treatment Market Top Player’s Company Profiles
- Pfizer Inc. (US)
- Novo Nordisk A/S (Denmark)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Bayer AG (Germany)
- Shire (Ireland)
- CSL Behring (Australia)
- Grifols, S.A. (Spain)
- Biogen Inc. (US)
- Sanofi S.A. (France)
- BioMarin Pharmaceutical Inc. (US)
- Takeda Pharmaceutical Company Limited (Japan)
- Octapharma AG (Switzerland)
- Sobi (Sweden)
- Pfizer Inc. (US)
- Bayer AG (Germany)
- Novartis AG (Switzerland)
- Sangamo Therapeutics, Inc. (US)
- Spark Therapeutics (US)
- Swedish Orphan Biovitrum AB (Sweden)
- Bioverativ Inc. (US)
Hemophilia Treatment Market Recent Developments
- In March 2022, in its Phase 1/2 B-LIEVE dose-confirmation clinical trial of FLT180a for the treatment of haemophilia B, a crippling genetic bleeding illness brought on by a lack in the clotting factor IX protein, Freeline Therapeutics Holdings plc dosed the first patient.
- In February 2022, at the 15th Annual Virtual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD), BioMarin Pharmaceutical Inc. presented encouraging findings from a two-year analysis of the Phase 3 GENEr8-1 study and an overall safety update of valoctocogene roxaparvovec, an investigational gene therapy for the treatment of adults with severe haemophilia A.
Hemophilia Treatment Key Market Trends
- Shift towards the rise in market: One of the main reasons favorably affecting the market is the rising incidence of genetic disorders among people worldwide and the rising number of hemophilic patients. Additionally, major market firms are benefiting from lucrative expansion potential due to the illness's rising diagnosis rate and the growing acceptance of preventative treatments for haemophilia. In addition, regulatory bodies in many nations are running a number of campaigns to raise awareness of the advantages of early diagnosis and the need to follow the right processes to make it easier to test newborns early, which is encouraging the market. Additionally, because there are few treatment choices available, they are sponsoring research and development (R&D) efforts more and more.
Hemophilia Treatment Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global Hemophilia Treatment market analysis, the market is a growing sector focused on providing therapies for individuals with hemophilia, a genetic disorder impairing blood clotting. Factors such as advanced medical technology, increased awareness, and better healthcare access have contributed to its expansion. Treatments include clotting factor concentrates and gene therapy, addressing the unique needs of patients. Clotting factor concentrates replace missing factors, reducing bleeding risks. Gene therapy aims to correct the genetic defects causing hemophilia. The market is driven by rising prevalence, healthcare expenditure, and personalized medicine trends. North America dominated the market, but Asia-Pacific is also growing due to improved infrastructure and investments. The market is dynamic, seeking to improve outcomes and find a cure through research and innovation. Overall, the market strives to provide effective therapeutic options for individuals with hemophilia, enhancing their quality of life.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 12.60 billion |
| Market size value in 2031 | USD 22.40 billion |
| Growth Rate | 6.6% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Hemophilia Treatment Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Hemophilia Treatment Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Hemophilia Treatment Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Hemophilia Treatment Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Hemophilia Treatment Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Hemophilia Treatment Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
